Catch me if you can: Leukemia Escape after CD19-Directed T Cell Immunotherapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Catch me if you can: Leukemia Escape after CD19-Directed T Cell Immunotherapies

Published:2016 Issue: Volume:14 Page:357-362
ISSN:2001-0370
Container-title:Computational and Structural Biotechnology Journal
language:en
Short-container-title:Computational and Structural Biotechnology Journal

Author:

Ruella Marco,Maus Marcela V.

Funder

EMD-Serono Cancer Immunotherapy Clinical Fellowship

Bristol-Myers Squibb Oncology Fellowship in Clinical Cancer Research

Gabrielle's Angel Foundation

SIES-AIL

NCI

Publisher

Elsevier BV

Subject

Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology

Reference58 articles.

1. Adoptive immunotherapy for cancer;Ruella;Immunol Rev,2014

2. Chimeric antigen receptor T cells for B cell neoplasms: choose the right CAR for you;Ruella;Curr Hematol Malig Rep,2016

3. How to train your T cell: genetically engineered chimeric antigen receptor T cells versus bispecific T-cell engagers to target CD19 in B acute lymphoblastic leukemia;Ruella;Expert Opin Biol Ther,2015

4. FDA approval: blinatumomab;Przepiorka;Clin Cancer Res,2015

5. Mode of cytotoxic action of T cell-engaging BiTE antibody MT110;Haas;Immunobiology,2009

Cited by 239 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting;Molecular Therapy;2024-09

2. CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma;Nature Communications;2024-07-23

3. CD5 deletion enhances the antitumor activity of adoptive T cell therapies;Science Immunology;2024-07-19

4. Immune-inflammatory modulation by natural products derived from edible and medicinal herbs used in Chinese classical prescriptions;Phytomedicine;2024-07

5. Universal CAR 2.0 to overcome current limitations in CAR therapy;Frontiers in Immunology;2024-06-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3